Delivery of Drugs Bound to erythrocytes: New Avenues for an Old Intravascular Carrier

References

• Abuchowski A McCoy JR Palczuk NC van Es T Davis FF . Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem.252 (11), 3582–3586 (1977).
   PubMed Web of Science ®Google Scholar
• Dumez H Reinhart WH Guetens G de Bruijn EA . Human red blood cells: rheological aspects, uptake, and release of cytotoxic drugs. Crit. Rev. Clin. Lab. Sci.41 (2), 159–188 (2004).
   PubMed Web of Science ®Google Scholar
• Farrell CL Pardridge WM . Blood–brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc. Natl Acad. Sci. USA88 (13), 5779–5783 (1991).
   PubMed Web of Science ®Google Scholar
• Haspel HC Stephenson KN Davies-Hill T et al. Effects of barbiturates on facilitative glucose transporters are pharmacologically specific and isoform selective. J. Membr. Biol.169 (1), 45–53 (1999).
   PubMed Web of Science ®Google Scholar
• Waite CL Roth CM . Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit. Rev. Biomed. Eng.40 (1), 21–41 (2012).
   PubMedGoogle Scholar
• Wang D Pascual JM Yang H et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann. Neurol.57 (1), 111–118 (2005).
   PubMed Web of Science ®Google Scholar
• Yang H Wang D Engelstad K et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann. Neurol.70 (6), 996–1005 (2011).
   PubMed Web of Science ®Google Scholar
• Armstead WM Ganguly K Kiessling JW et al. Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders. J. Neurochem.113 (2), 303–312 (2010).
   PubMed Web of Science ®Google Scholar
• Collen D Lijnen HR . Thrombolytic agents. Thromb. Haemost.93 (4), 627–630 (2005).
   PubMed Web of Science ®Google Scholar
• Farokhzad OC Langer R . Impact of nanotechnology on drug delivery. ACS Nano3 (1), 16–20 (2009).
   PubMed Web of Science ®Google Scholar
• Muro S Garnacho C Champion JA et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. J. Am. Soc. Gene Ther.16 (8), 1450–1458 (2008).
   PubMed Web of Science ®Google Scholar
• Nordt TK Bode C . Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart Br. Card. Soc.89 (11), 1358–1362 (2003).
   PubMed Web of Science ®Google Scholar
• Petros RA DeSimone JM . Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov.9 (8), 615–627 (2010).
   PubMed Web of Science ®Google Scholar
• Shuvaev VV Ilies MA Simone E et al. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano5 (9), 6991–6999 (2011).
   PubMed Web of Science ®Google Scholar
• Magnani M . Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching. Expert Opin. Biol. Ther.12 (2), 137–138 (2012).
   PubMed Web of Science ®Google Scholar
• Muzykantov VR . Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin. Drug Deliv.7 (4), 403–427 (2010).
   PubMed Web of Science ®Google Scholar
• Coller BS Springer KT Beer JH et al. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J. Clin. Invest.89 (2), 546–555 (1992).
   PubMed Web of Science ®Google Scholar
• Dale GL Kuhl W Beutler E . Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro. Proc. Natl Acad. Sci. USA76 (1), 473–475 (1979).
   PubMed Web of Science ®Google Scholar
• Muzykantov VR Sakharov DV Smirnov MD Samokhin GP Smirnov VN . Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim. Biophys. Acta884 (2), 355–362 (1986).
   PubMed Web of Science ®Google Scholar
• Ihler GM Glew RH Schnure FW . Enzyme loading of erythrocytes. Proc. Natl Acad. Sci. USA70 (9), 2663–2666 (1973).
   PubMed Web of Science ®Google Scholar
• Alvarez FJ Herráez A Murciano JC Jordán JA Díez JC Tejedor MC . In vivo survival and organ uptake of loaded carrier rat erythrocytes. J. Biochem. (Tokyo)120 (2), 286–291 (1996).
   PubMed Web of Science ®Google Scholar
• Pérez MT Alvarez FJ García-Pérez AI Lucas L Tejedor MC Sancho P . Heterogeneity of hypotonically loaded rat erythrocyte populations as detected by counter-current distribution in aqueous polymer two-phase systems. J. Chromatogr. B Biomed. Appl.677 (1), 45–51 (1996).
   PubMed Web of Science ®Google Scholar
• Ktavtzoff R Desbois I Doinel C et al. Immunological response to L-asparaginase loaded into red blood cells. Adv. Exp. Med. Biol.326, 175–182 (1992).
   PubMedGoogle Scholar
• Rossi L Serafini S Cappellacci L et al. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus. J. Antimicrob. Chemother.47 (6), 819–827 (2001).
   PubMed Web of Science ®Google Scholar
• Tonetti M Astroff B Satterfield W De Flora A Benatti U DeLoach JR . Construction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery system. Biotechnol. Appl. Biochem.12 (6), 621–629 (1990).
   PubMed Web of Science ®Google Scholar
• Kim S-H Kim E-J Hou J-H et al. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides. Biomaterials30 (5), 959–967 (2009).
   PubMed Web of Science ®Google Scholar
• Teisseire B Ropars C Villeréal MC Nicolau C . Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes. Proc. Natl Acad. Sci. USA84 (19), 6894–6898 (1987).
   PubMed Web of Science ®Google Scholar
• Bax BE Bain MD Fairbanks LD Webster AD Chalmers RA . In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase. Br. J. Haematol.109 (3), 549–554 (2000).
   PubMed Web of Science ®Google Scholar
• Hambÿe AS Verbeke KA Vandermeiren RP Joosens EJ Verbruggen AM De Roo MJ . Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography. J. Nucl. Med. Off. Publ. Soc. Nucl. Med.38 (10), 1521–1528 (1997).
   PubMed Web of Science ®Google Scholar
• Kravtzoff R Colombat PH Desbois I et al. Tolerance evaluation of L-asparaginase loaded in red blood cells. Eur. J. Clin. Pharmacol.51 (3–4), 221–225 (1996).
   PubMed Web of Science ®Google Scholar
• Kravtzoff R Desbois I Lamagnere JP et al. Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells. Eur. J. Clin. Pharmacol.49 (6), 465–470 (1996).
   PubMed Web of Science ®Google Scholar
• Hamidi M Zarrin A Foroozesh M Mohammadi-Samani S . Applications of carrier erythrocytes in delivery of biopharmaceuticals. J. Control. Release118 (2), 145–160 (2007).
   PubMed Web of Science ®Google Scholar
• Krantz A . Red cell-mediated therapy: opportunities and challenges. Blood Cells. Mol Dis.23 (1), 58–68 (1997).
   PubMedGoogle Scholar
• Patel PD Dand N Hirlekar RS Kadam VJ . Drug loaded erythrocytes: as novel drug delivery system. Curr. Pharm. Des.14 (1), 63–70 (2008).
   PubMed Web of Science ®Google Scholar
• Pierigè F Serafini S Rossi L Magnani M . Cell-based drug delivery. Adv. Drug Deliv. Rev.60 (2), 286–295 (2008).
   PubMed Web of Science ®Google Scholar
• Rossi L Serafini S Pierigé F et al. Erythrocyte-based drug delivery. Expert Opin. Drug Deliv.2 (2), 311–322 (2005).
   PubMedGoogle Scholar
• Bax BE Bain MD Fairbanks LD et al. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. Eur. J. Haematol.79 (4), 338–348 (2007).
   PubMed Web of Science ®Google Scholar
• Bax BE Bain MD Scarpelli M Filosto M Tonin P Moran N . Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement. Neurology81 (14), 1269–1271 (2013).
   PubMed Web of Science ®Google Scholar
• Godfrin Y Horand F Franco R et al. International seminar on the red blood cells as vehicles for drugs. Expert Opin. Biol. Ther.12 (1), 127–133 (2012).
   PubMed Web of Science ®Google Scholar
• Domenech C Thomas X Chabaud S et al. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005–01 randomized trial. Br. J. Haematol.153 (1), 58–65 (2011).
   PubMed Web of Science ®Google Scholar
• Bossa F Latiano A Rossi L et al. Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study. Am. J. Gastroenterol.103 (10), 2509–2516 (2008).
   PubMed Web of Science ®Google Scholar
• Bossa F Annese V Valvano MR et al. Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind Sham-controlled study. Inflamm. Bowel Dis.19 (9), 1872–1879 (2013).
   PubMed Web of Science ®Google Scholar
• Mohandas N Gallagher PG . Red cell membrane: past, present, and future. Blood112 (10), 3939–3948 (2008).
   PubMed Web of Science ®Google Scholar
• Sosa JM Nielsen ND Vignes SM Chen TG Shevkoplyas SS . The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network. Clin. Hemorheol. Microcirc.57 (3), 275–289 (2013).
   Web of Science ®Google Scholar
• Tracz MJ Alam J Nath KA . Physiology and pathophysiology of heme: implications for kidney disease. J. Am. Soc. Nephrol.18 (2), 414–420 (2007).
   PubMed Web of Science ®Google Scholar
• Schaer DJ Buehler PW Alayash AI Belcher JD Vercellotti GM . Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood121 (8), 1276–1284 (2013).
   PubMed Web of Science ®Google Scholar
• Janatpour KA Kalmin ND Jensen HM Holland PV . Clinical outcomes of ABO-incompatible RBC transfusions. Am. J. Clin. Pathol.129 (2), 276–281 (2008).
   PubMed Web of Science ®Google Scholar
• Pasini EM Kirkegaard M Mortensen P Lutz HU Thomas AW Mann M . In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood108 (3), 791–801 (2006).
   PubMed Web of Science ®Google Scholar
• Kalfa TA Pushkaran S Mohandas N et al. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood108 (12), 3637–3645 (2006).
   PubMed Web of Science ®Google Scholar
• Vink H Duling BR . Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res.79 (3), 581–589 (1996).
   PubMed Web of Science ®Google Scholar
• Nans A Mohandas N Stokes DL . Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography. Biophys. J.101 (10), 2341–2350 (2011).
   PubMed Web of Science ®Google Scholar
• Sathi A Viswanad V Aneesh TP Kumar BA . Pros and cons of phospholipid asymmetry in erythrocytes. J. Pharm. Bioallied Sci.6 (2), 81–85 (2014).
   PubMedGoogle Scholar
• Lubin B Chiu D Bastacky J Roelofsen B Van Deenen LL . Abnormalities in membrane phospholipid organization in sickled erythrocytes. J. Clin. Invest.67 (6), 1643–1649 (1981).
   PubMed Web of Science ®Google Scholar
• An X Mohandas N . Disorders of red cell membrane. Br. J. Haematol.141 (3), 367–375 (2008).
   PubMed Web of Science ®Google Scholar
• Barcellini W Bianchi P Fermo E et al. Hereditary red cell membrane defects: diagnostic and clinical aspects. Blood Transfus. Trasfus. Sangue.9 (3), 274–277 (2011).
   PubMed Web of Science ®Google Scholar
• Reliene R Mariani M Zanella A et al. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood100 (6), 2208–2215 (2002).
   PubMed Web of Science ®Google Scholar
• Ganguly K Murciano J-C Westrick R Leferovich J Cines DB Muzykantov VR . The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition. J. Pharmacol. Exp. Ther.321 (1), 158–164 (2007).
   PubMed Web of Science ®Google Scholar
• Chang TMS . From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif. Cells Blood Substit. Immobil. Biotechnol.40 (3), 197–199 (2012).
   PubMed Web of Science ®Google Scholar
• Habler O Pape A Meier J Zwissler B . [Artificial oxygen carriers as an alternative to red blood cell transfusion]. Anaesthesist54 (8), 741–754 (2005).
   PubMed Web of Science ®Google Scholar
• Zaltzman AB Van den Berg CW Muzykantov VR Morgan BP . Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor. Biochem. J.307 (Pt 3), 651–656 (1995).
   PubMedGoogle Scholar
• Oldenborg PA Zheleznyak A Fang YF Lagenaur CF Gresham HD Lindberg FP . Role of CD47 as a marker of self on red blood cells. Science288 (5473), 2051–2054 (2000).
   PubMed Web of Science ®Google Scholar
• Ishikawa-Sekigami T Kaneko Y Okazawa H et al. SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. Blood107 (1), 341–348 (2006).
   PubMed Web of Science ®Google Scholar
• Burger P Hilarius-Stokman P de Korte D van den Berg TK van Bruggen R . CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood119 (23), 5512–5521 (2012).
   PubMed Web of Science ®Google Scholar
• Kuriyama T Takenaka K Kohno K et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood120 (19), 4058–4067 (2012).
   PubMed Web of Science ®Google Scholar
• Kinoshita T Medof ME Silber R Nussenzweig V . Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med.162 (1), 75–92 (1985).
   PubMed Web of Science ®Google Scholar
• Medof ME Kinoshita T Nussenzweig V . Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med.160 (5), 1558–1578 (1984).
   PubMed Web of Science ®Google Scholar
• Nicholson-Weller A March JP Rosenfeld SI Austen KF . Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc. Natl Acad. Sci. USA80 (16), 5066–5070 (1983).
   PubMed Web of Science ®Google Scholar
• Pangburn MK Schreiber RD Müller-Eberhard HJ . Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc. Natl Acad. Sci. USA80 (17), 5430–5434 (1983).
   PubMed Web of Science ®Google Scholar
• Schultz DR . Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria. Am. J. Med.87 (3N), 22N–29N (1989).
   PubMedGoogle Scholar
• Sugita Y Ito K Shiozuka K et al. Recombinant soluble CD59 inhibits reactive haemolysis with complement. Immunology82 (1), 34–41 (1994).
   Web of Science ®Google Scholar
• Beppu M Mizukami A Nagoya M Kikugawa K . Binding of anti-band 3 autoantibody to oxidatively damaged erythrocytes. Formation of senescent antigen on erythrocyte surface by an oxidative mechanism. J. Biol. Chem.265 (6), 3226–3233 (1990).
   Web of Science ®Google Scholar
• Galili U Flechner I Knyszynski A Danon D Rachmilewitz EA . The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br. J. Haematol.62 (2), 317–324 (1986).
   Web of Science ®Google Scholar
• Giger U Sticher B Naef R Burger R Lutz HU . Naturally occurring human anti-band 3 autoantibodies accelerate clearance of erythrocytes in guinea pigs. Blood85 (7), 1920–1928 (1995).
   Web of Science ®Google Scholar
• Kay MM . Isolation of the phagocytosis-inducing IgG-binding antigen on senescent somatic cells. Nature289 (5797), 491–494 (1981).
   Web of Science ®Google Scholar
• Cambos M Scorza T . Robust erythrophagocytosis leads to macrophage apoptosis via a hemin-mediated redox imbalance: role in hemolytic disorders. J. Leukoc. Biol.89 (1), 159–171 (2011).
   Web of Science ®Google Scholar
• Loegering DJ Commins LM Minnear FL Gary LA Hill LA . Effect of Kupffer cell phagocytosis of erythrocytes and erythrocyte ghosts on susceptibility to endotoxemia and bacteremia. Infect. Immun.55 (9), 2074–2080 (1987).
   Web of Science ®Google Scholar
• Mebius RE Kraal G . Structure and function of the spleen. Nat. Rev. Immunol.5 (8), 606–616 (2005).
   PubMed Web of Science ®Google Scholar
• Alvarez FJ Jordán JA Calleja P et al. Cross-linking treatment of loaded erythrocytes increases delivery of encapsulated substance to macrophages. Biotechnol. Appl. Biochem.27 (Pt 2), 139–143 (1998).
   Google Scholar
• Chiarantini L Rossi L Fraternale A Magnani M . Modulated red blood cell survival by membrane protein clustering. Mol. Cell. Biochem.144 (1), 53–59 (1995).
   PubMed Web of Science ®Google Scholar
• Paulitschke M Nash GB Anstee DJ Tanner MJ Gratzer WB . Perturbation of red blood cell membrane rigidity by extracellular ligands. Blood86 (1), 342–348 (1995).
   PubMed Web of Science ®Google Scholar
• Rancourt C Robertson MW Wang M et al. Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.4 (2), 265–270 (1998).
   Web of Science ®Google Scholar
• Turrini F Arese P Yuan J Low PS . Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J. Biol. Chem.266 (35), 23611–23617 (1991).
   PubMed Web of Science ®Google Scholar
• Lisovskaya IL Shcherbachenko IM Volkova RI Ataullakhanov FI . Clotrimazole enhances lysis of human erythrocytes induced by t-BHP. Chem. Biol. Interact.180 (3), 433–439 (2009).
   PubMed Web of Science ®Google Scholar
• Turrini F Mannu F Arese P Yuan J Low PS . Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins. Blood81 (11), 3146–3152 (1993).
   Web of Science ®Google Scholar
• Geldwerth D Helley D de Jong K et al. Detection of phosphatidylserine surface exposure on human erythrocytes using annexin V-ferrofluid. Biochem. Biophys. Res. Commun.258 (1), 199–203 (1999).
   Web of Science ®Google Scholar
• Closse C Dachary-Prigent J Boisseau MR . Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol.107 (2), 300–302 (1999).
   PubMed Web of Science ®Google Scholar
• Chiarantini L Johnson J Deloach JR . Optimized recirculation survival of mouse carrier erythrocytes. Blood Cells17 (3), 607–617 ; discussion 618–622 (1991).
   Google Scholar
• Eichler HG Gasic S Bauer K Korn A Bacher S . In vivo clearance of antibody-sensitized human drug carrier erythrocytes. Clin. Pharmacol. Ther.40 (3), 300–303 (1986).
   PubMed Web of Science ®Google Scholar
• Grover GJ Loegering DJ . Effect of red blood cell stroma on the reticuloendothelial system clearance and killing of Streptococcus pneumoniae. Circ. Shock14 (1), 39–47 (1984).
   Google Scholar
• Van Wijk R van Solinge WW . The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood106 (13), 4034–4042 (2005).
   PubMed Web of Science ®Google Scholar
• Dejam A Hunter CJ Pelletier MM et al. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood106 (2), 734–739 (2005).
   PubMed Web of Science ®Google Scholar
• Alvarez FJ Jordán JA Herráez A Díez JC Tejedor MC . Hypotonically loaded rat erythrocytes deliver encapsulated substances into peritoneal macrophages. J. Biochem. (Tokyo)123 (2), 233–239 (1998).
   Web of Science ®Google Scholar
• Humphreys JD Ihler G . Enhanced stability of erythrocyte-entrapped glucocerebrosidase activity. J. Lab. Clin. Med.96 (4), 682–692 (1980).
   Web of Science ®Google Scholar
• Chiarantini L Antonelli A Rossi L Fraternale A Magnani M . Red blood cell phagocytosis following hexokinase inactivation. Cell Biochem. Funct.12 (3), 217–220 (1994).
   Web of Science ®Google Scholar
• Franchetti P Cappellacci L Petrelli R et al. Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir. Nucleosides Nucleotides Nucleic Acids26 (8–9), 953–957 (2007).
   PubMed Web of Science ®Google Scholar
• Magnani M Casabianca A Fraternale A et al. Inhibition of murine AIDS by a new azidothymidine homodinucleotide. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.17 (3), 189–195 (1998).
   Google Scholar
• Rossi L Brandi G Schiavano GF et al. Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol. AIDS Res. Hum. Retroviruses15 (4), 345–353 (1999).
   PubMed Web of Science ®Google Scholar
• Chiarantini L Droleskey R Magnani M DeLoach JR . In vitro targeting of erythrocytes to cytotoxic T-cells by coupling of Thy-1.2 monoclonal antibody. Biotechnol. Appl. Biochem.15 (2), 171–184 (1992).
   Web of Science ®Google Scholar
• Magnani M Rossi L Fraternale A et al. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther.9 (11), 749–751 (2002).
   PubMed Web of Science ®Google Scholar
• Mukthavaram R Shi G Kesari S Simberg D . Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes. J. Control. Release183, 146–153 (2014).
   PubMed Web of Science ®Google Scholar
• Muzykantov VR Zaltsman AB Smirnov MD Samokhin GP Morgan BP . Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement. Biochim. Biophys. Acta1279 (2), 137–143 (1996).
   Web of Science ®Google Scholar
• Magnani M Mancini U Bianchi M Fazi A . Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. Adv. Exp. Med. Biol.326, 189–194 (1992).
   PubMedGoogle Scholar
• Muzykantov VR Sakharov DV Domogatsky SP Goncharov NV Danilov SM . Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide. Am. J. Pathol.128 (2), 276–285 (1987).
   Web of Science ®Google Scholar
• Muzykantov VR Smirnov MD Zaltzman AB Samokhin GP . Tannin-mediated attachment of avidin provides complement-resistant immunoerythrocytes that can be lysed in the presence of activator of complement. Anal. Biochem.208 (2), 338–342 (1993).
   Web of Science ®Google Scholar
• Godfrey W Doe B Wallace EF Bredt B Wofsy L . Affinity targeting of membrane vesicles to cell surfaces. Exp. Cell Res.135 (1), 137–145 (1981).
   Web of Science ®Google Scholar
• Orr GA . The use of the 2-iminobiotin-avidin interaction for the selective retrieval of labeled plasma membrane components. J. Biol. Chem.256 (2), 761–766 (1981).
   PubMed Web of Science ®Google Scholar
• Roffman E Meromsky L Ben-Hur H Bayer EA Wilchek M . Selective labeling of functional groups on membrane proteins or glycoproteins using reactive biotin derivatives and 125I-streptavidin. Biochem. Biophys. Res. Commun.136 (1), 80–85 (1986).
   Web of Science ®Google Scholar
• Bayer EA Safars M Wilchek M . Selective labeling of sulfhydryls and disulfides on blot transfers using avidin-biotin technology: studies on purified proteins and erythrocyte membranes. Anal. Biochem.161 (2), 262–271 (1987).
   PubMed Web of Science ®Google Scholar
• Wilchek M Ben-Hur H Bayer EA . p-Diazobenzoyl biocytin–a new biotinylating reagent for the labeling of tyrosines and histidines in proteins. Biochem. Biophys. Res. Commun.138 (2), 872–879 (1986).
   Web of Science ®Google Scholar
• Muzykantov VR Smirnov MD Klibanov AL . Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes. J. Immunol. Methods158 (2), 183–190 (1993).
   Web of Science ®Google Scholar
• Samokhin GP Smirnov MD Muzykantov VR Domogatsky SP Smirnov VN . Red blood cell targeting to collagen-coated surfaces. FEBS Lett.154 (2), 257–261 (1983).
   Web of Science ®Google Scholar
• Cowley H Wojda U Cipolone KM Procter JL Stroncek DF Miller JL . Biotinylation modifies red cell antigens. Transfusion39 (2), 163–168 (1999).
   Web of Science ®Google Scholar
• Magnani M Chiarantini L Mancini U . Preparation and characterization of biotinylated red blood cells. Biotechnol. Appl. Biochem.20 (Pt 3), 335–345 (1994).
   Google Scholar
• Magnani M Rossi L D'ascenzo M Panzani I Bigi L Zanella A . Erythrocyte engineering for drug delivery and targeting. Biotechnol. Appl. Biochem.28 (Pt 1), 1–6 (1998).
   Google Scholar
• Muzykantov VR Sakharov DV Smirnov MD Domogatsky SP Samokhin GP . Targeting of enzyme immobilized on erythrocyte membrane to collagen-coated surface. FEBS Lett.182 (1), 62–66 (1985).
   Web of Science ®Google Scholar
• Smirnov MD Samokhin GP Muzykantov VR Idelson GL Domogatsky SP Smirnov VN . Type I and III collagens as a possible target for drug delivery to the injured sites of vascular bed. Biochem. Biophys. Res. Commun.116 (1), 99–105 (1983).
   Web of Science ®Google Scholar
• Muzykantov VR Smirnov MD Samokhin GP . Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway. FEBS Lett.280 (1), 112–114 (1991).
   Web of Science ®Google Scholar
• Hoffman JF . On red blood cells, hemolysis and resealed ghosts. Adv. Exp. Med. Biol.326, 1–15 (1992).
   PubMedGoogle Scholar
• Muzykantov VR Smirnov MD Samokhin GP . Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement. Blood78 (10), 2611–2618 (1991).
   Web of Science ®Google Scholar
• Muzykantov VR Seregina N Smirnov MD . Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes. Int. J. Artif. Organs15 (10), 622–627 (1992).
   PubMed Web of Science ®Google Scholar
• Muzykantov VR Smirnov MD Klibanov AL . Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement. FEBS Lett.318 (2), 108–112 (1993).
   Web of Science ®Google Scholar
• Muzykantov VR Murciano JC . Attachment of antibody to biotinylated red blood cells: immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats. Biotechnol. Appl. Biochem.24 (Pt 1), 41–45 (1996).
   Google Scholar
• Muzykantov VR Taylor RP . Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement. Anal. Biochem.223 (1), 142–148 (1994).
   PubMed Web of Science ®Google Scholar
• Muzykantov VR Smirnov MD Samokhin GP . Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes. Biochem. J.273 (Pt 2), 393–397 (1991).
   Google Scholar
• Muzykantov VR Smirnov MD Samokhin GP . Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane. Biochim. Biophys. Acta1107 (1), 119–125 (1992).
   Google Scholar
• Muzykantov VR Murciano JC Taylor RP Atochina EN Herraez A . Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin. Anal. Biochem.241 (1), 109–119 (1996).
   PubMed Web of Science ®Google Scholar
• Chiarantini L Argnani R Zucchini S et al. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice. Vaccine15 (3), 276–280 (1997).
   Web of Science ®Google Scholar
• Smirnov VN Domogatsky SP Dolgov VV et al. Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc. Natl Acad. Sci. USA83 (17), 6603–6607 (1986).
   Web of Science ®Google Scholar
• Gyimesi E Bankovich AJ Schuman TA Goldberg JB Lindorfer MA Taylor RP . Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages. Immunol. Lett.95 (2), 185–192 (2004).
   Web of Science ®Google Scholar
• Kuhn SE Nardin A Klebba PE Taylor RP . Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J. Immunol.160 (10), 5088–5097 (1998).
   Web of Science ®Google Scholar
• Taylor RP Sutherland WM Reist CJ Webb DJ Wright EL Labuguen RH . Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc. Natl Acad. Sci. USA88 (8), 3305–3309 (1991).
   PubMed Web of Science ®Google Scholar
• Spitzer D Unsinger J Bessler M Atkinson JP . ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement. Mol. Immunol.40 (13), 911–919 (2004).
   Web of Science ®Google Scholar
• Suzuki K Okumura Y . GPI-linked proteins do not transfer spontaneously from erythrocytes to liposomes. New aspects of reorganization of the cell membrane. Biochemistry (Mosc.)39 (31), 9477–9485 (2000).
   Google Scholar
• Civenni G Test ST Brodbeck U Bütikofer P . In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane. Blood91 (5), 1784–1792 (1998).
   Web of Science ®Google Scholar
• Medof ME Nagarajan S Tykocinski ML . Cell-surface engineering with GPI-anchored proteins. FASEB J.10 (5), 574–586 (1996).
   PubMed Web of Science ®Google Scholar
• Hill A Ridley SH Esser D et al. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. Blood107 (5), 2131–2137 (2006).
   Web of Science ®Google Scholar
• Chen R Walter EI Parker G et al. Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylation. Proc. Natl Acad. Sci. USA95 (16), 9512–9517 (1998).
   Web of Science ®Google Scholar
• Kooyman DL Byrne GW McClellan S et al. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science269 (5220), 89–92 (1995).
   PubMed Web of Science ®Google Scholar
• Müller M Büchi L Woodtli K Haeberli A Beer JH . Preparation and characterization of “heparinocytes”: erythrocytes with covalently bound low molecular weight heparin. FEBS Lett.468 (2–3), 115–119 (2000).
   Web of Science ®Google Scholar
• Holvoet P Laroche Y Stassen JM et al. Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody fused to single-chain urokinase. Blood81 (3), 696–703 (1993).
   Web of Science ®Google Scholar
• Topol EJ Morris DC Smalling RW et al. A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction. J. Am. Coll. Cardiol.9 (6), 1205–1213 (1987).
   Web of Science ®Google Scholar
• Narita M Bu G Herz J Schwartz AL . Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J. Clin. Invest.96 (2), 1164–1168 (1995).
   PubMed Web of Science ®Google Scholar
• Collen D Van Hoef B Schlott B Hartmann M Gührs KH Lijnen HR . Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. Eur. J. Biochem. FEBS216 (1), 307–314 (1993).
   Google Scholar
• Holvoet P Dewerchin M Stassen JM et al. Thrombolytic profiles of clot-targeted plasminogen activators. Parameters determining potency and initial and maximal rates. Circulation87 (3), 1007–1016 (1993).
   Web of Science ®Google Scholar
• Muzykantov VR Barnathan ES Atochina EN Kuo A Danilov SM Fisher AB . Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature. J. Pharmacol. Exp. Ther.279 (2), 1026–1034 (1996).
   PubMed Web of Science ®Google Scholar
• Runge MS Harker LA Bode C et al. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation94 (6), 1412–1422 (1996).
   Web of Science ®Google Scholar
• Wang YF Tsirka SE Strickland S Stieg PE Soriano SG Lipton SA . Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med.4 (2), 228–231 (1998).
   PubMed Web of Science ®Google Scholar
• Gersh KC Zaitsev S Muzykantov V Cines DB Weisel JW . The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics. J. Thromb. Haemost. JTH8 (5), 1066–1074 (2010).
   PubMed Web of Science ®Google Scholar
• Gersh KC Zaitsev S Cines DB Muzykantov V Weisel JW . Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent. Blood117 (18), 4964–4967 (2011).
   PubMed Web of Science ®Google Scholar
• Ganguly K Krasik T Medinilla S et al. Blood clearance and activity of erythrocyte-coupled fibrinolytics. J. Pharmacol. Exp. Ther.312 (3), 1106–1113 (2005).
   PubMed Web of Science ®Google Scholar
• Murciano J-C Medinilla S Eslin D Atochina E Cines DB Muzykantov VR . Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nat. Biotechnol.21 (8), 891–896 (2003).
   PubMed Web of Science ®Google Scholar
• Armstead WM Cines DB Higazi AA-R . Plasminogen activators contribute to impairment of hypercapnic and hypotensive cerebrovasodilation after cerebral hypoxia/ischemia in the newborn pig. Stroke J. Cereb. Circ.36 (10), 2265–2269 (2005).
   Google Scholar
• Armstead WM Christine AJ Higazi AA-R Cines DB . Urokinase plasminogen activator impairs SNP and PGE2 cerebrovasodilation after brain injury through activation of LRP and ERK MAPK. J. Neurotrauma25 (11), 1375–1381 (2008).
   Web of Science ®Google Scholar
• Armstead WM Ganguly K Kiessling JW et al. Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK activation. J. Cereb. Blood Flow Metab.29 (8), 1463–1474 (2009).
   PubMed Web of Science ®Google Scholar
• Armstead WM Ganguly K Riley J et al. Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig. Pediatr. Crit. Care Med.12 (6), e369–e375 (2011).
   PubMed Web of Science ®Google Scholar
• Murciano J-C Higazi AA-R Cines DB Muzykantov VR . Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile. J. Control. Release139 (3), 190–196 (2009).
   Web of Science ®Google Scholar
• Danielyan K Ganguly K Ding B-S et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation118 (14), 1442–1449 (2008).
   PubMed Web of Science ®Google Scholar
• Pisapia JM Xu X Kelly J et al. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan. Exp. Neurol.233 (1), 357–363 (2012).
   PubMed Web of Science ®Google Scholar
• Stein SC Ganguly K Belfield CM et al. Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury. J. Neurotrauma26 (9), 1585–1592 (2009).
   PubMed Web of Science ®Google Scholar
• Hess C Schifferli JA . Immune adherence revisited: novel players in an old game. News Physiol. Sci.18, 104–108 (2003).
   PubMedGoogle Scholar
• Fearon DT . Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med.152 (1), 20–30 (1980).
   Web of Science ®Google Scholar
• Krych-Goldberg M Atkinson JP . Structure-function relationships of complement receptor type 1. Immunol. Rev.180, 112–122 (2001).
   PubMed Web of Science ®Google Scholar
• Lindorfer MA Hahn CS Foley PL Taylor RP . Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol. Rev.183, 10–24 (2001).
   PubMed Web of Science ®Google Scholar
• Nickells M Hauhart R Krych M et al. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin. Exp. Immunol.112 (1), 27–33 (1998).
   Web of Science ®Google Scholar
• Nardin A Sutherland WM Hevey M Schmaljohn A Taylor RP . Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes. J. Immunol. Methods211 (1–2), 21–31 (1998).
   Web of Science ®Google Scholar
• Taylor RP Reist CJ Sutherland WM Otto A Labuguen RH Wright EL . In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor. J. Immunol.148 (8), 2462–2468 (1992).
   PubMed Web of Science ®Google Scholar
• Repik A Pincus SE Ghiran I et al. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin. Exp. Immunol.140 (2), 230–240 (2005).
   Web of Science ®Google Scholar
• Reinagel ML Gezen M Ferguson PJ Kuhn S Martin EN Taylor RP . The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood89 (3), 1068–1077 (1997).
   Web of Science ®Google Scholar
• Nardin A Lindorfer MA Taylor RP . How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?Mol. Immunol.36 (13–14), 827–835 (1999).
   Web of Science ®Google Scholar
• Craig ML Bankovich AJ Taylor RP . Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages. Clin. Immunol.105 (1), 36–47 (2002).
   Web of Science ®Google Scholar
• Craig ML Waitumbi JN Taylor RP . Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J. Immunol.174 (5), 3059–3066 (2005).
   Web of Science ®Google Scholar
• Taylor RP Ferguson PJ Martin EN et al. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin. Immunol. Immunopathol.82 (1), 49–59 (1997).
   Google Scholar
• Ferguson PJ Martin EN Greene KL et al. Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys. J. Immunol.155 (1), 339–347 (1995).
   Web of Science ®Google Scholar
• Lindorfer MA Nardin A Foley PL et al. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J. Immunol.167 (4), 2240–2249 (2001).
   Web of Science ®Google Scholar
• Reist CJ Liang HY Denny D Martin EN Scheld WM Taylor RP . Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol.24 (9), 2018–2025 (1994).
   Web of Science ®Google Scholar
• Asher DR Cerny AM Finberg RW . The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proc. Natl Acad. Sci. USA102 (36), 12897–12902 (2005).
   Web of Science ®Google Scholar
• Hahn CS French OG Foley P Martin EN Taylor RP . Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J. Immunol.166 (2), 1057–1065 (2001).
   Web of Science ®Google Scholar
• Taylor RP Sutherland WM Martin EN et al. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model. J. Immunol.158 (2), 842–850 (1997).
   Web of Science ®Google Scholar
• Sharma R Zhao H Al-Saleem FH et al. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor. Mol. Immunol.57 (2), 247–254 (2014).
   PubMed Web of Science ®Google Scholar
• Craig ML Reinagel ML Martin EN Schlimgen R Nardin A Taylor RP . Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen. Clin. Immunol.92 (2), 170–180 (1999).
   Web of Science ®Google Scholar
• Ferguson PJ Reist CJ Martin EN et al. Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1. Arthritis Rheum.38 (2), 190–200 (1995).
   Google Scholar
• Pincus SE Lukacher N Mohamed N et al. Evaluation of antigen-based heteropolymer for treatment of systemic lupus erythematosus in a nonhuman primate model. Clin. Immunol.105 (2), 141–154 (2002).
   Web of Science ®Google Scholar
• Buster BL Mattes KA Scheld WM . Monoclonal antibody-mediated, complement-independent binding of human tumor necrosis factor-alpha to primate erythrocytes via complement receptor 1. J. Infect. Dis.176 (4), 1041–1046 (1997).
   Web of Science ®Google Scholar
• Zaitsev S Danielyan K Murciano J-C et al. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood108 (6), 1895–1902 (2006).
   PubMed Web of Science ®Google Scholar
• Chasis JA Mohandas N . Red blood cell glycophorins. Blood80 (8), 1869–1879 (1992).
   Web of Science ®Google Scholar
• Reid ME . Some concepts relating to the molecular genetic basis of certain MNS blood group antigens. Transfus. Med. Oxf. Engl.4 (2), 99–111 (1994).
   Web of Science ®Google Scholar
• Poole J . Red cell antigens on band 3 and glycophorin A. Blood Rev.14 (1), 31–43 (2000).
   Web of Science ®Google Scholar
• Ugorski M Blackall DP Påhlsson P Shakin-Eshleman SH Moore J Spitalnik SL . Recombinant Miltenberger I and II human blood group antigens: the role of glycosylation in cell surface expression and antigenicity of glycophorin A. Blood82 (6), 1913–1920 (1993).
   Web of Science ®Google Scholar
• Marchesi VT . The red cell membrane skeleton: recent progress. Blood61 (1), 1–11 (1983).
   Web of Science ®Google Scholar
• Hillyard CJ Rylatt DB Kemp BE Bundesen PG . Erythrocyte agglutination assay. www.google.com/patents/US5413913.
   Google Scholar
• Rozmyslowicz T Donnell ME Spitalnik SL Blackall DP . Recombinant blood group antigens are useful for studying the fine specificity of antibodies against glycophorin A encoded antigens. Transfus. Clin. Biol. J. Société Fr. Transfus. Sang.4 (1), 77–80 (1997).
   Web of Science ®Google Scholar
• Song SC Xie K Czerwinski M Spitalnik SL Wedekind JE . Purification, crystallization and x-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen. Acta Crystallogr. D Biol. Crystallogr.60 (Pt 4), 788–791 (2004).
   Google Scholar
• Czerwinski M Krop-Watorek A Siegel DL Spitalnik SL . A molecular approach for isolating high-affinity Fab fragments that are useful in blood group serology. Transfusion39 (4), 364–371 (1999).
   Web of Science ®Google Scholar
• Zaitsev S Spitzer D Murciano J-C et al. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood115 (25), 5241–5248 (2010).
   PubMed Web of Science ®Google Scholar
• Ding B-S Gottstein C Grunow A et al. Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. Blood106 (13), 4191–4198 (2005).
   PubMed Web of Science ®Google Scholar
• Runge MS Quertermous T Zavodny PJ et al. A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo. Proc. Natl Acad. Sci. USA88 (22), 10337–10341 (1991).
   Web of Science ®Google Scholar
• Oudin S Libyh MT Goossens D et al. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes. J. Immunol.164 (3), 1505–1513 (2000).
   Web of Science ®Google Scholar
• Kina T Ikuta K Takayama E et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol.109 (2), 280–287 (2000).
   Web of Science ®Google Scholar
• Spitzer D Unsinger J Mao D Wu X Molina H Atkinson JP . In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane. J. Immunol.175 (11), 7763–7770 (2005).
   Web of Science ®Google Scholar
• Spitzer D Wu X Ma X Xu L Ponder KP Atkinson JP . Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy. J. Immunol.177 (8), 4953–4956 (2006).
   Web of Science ®Google Scholar
• Zaitsev S Spitzer D Murciano J-C et al. Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis. J. Pharmacol. Exp. Ther.332 (3), 1022–1031 (2010).
   PubMed Web of Science ®Google Scholar
• Kumada T Dittman WA Majerus PW . A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood71 (3), 728–733 (1988).
   Web of Science ®Google Scholar
• Zaitsev S Kowalska MA Neyman M et al. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis. Blood119 (20), 4779–4785 (2012).
   PubMed Web of Science ®Google Scholar
• Kontos S Kourtis IC Dane KY Hubbell JA . Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc. Natl Acad. Sci. USA110 (1), E60–E68 (2013).
   PubMed Web of Science ®Google Scholar
• Reid ME Mohandas N . Red blood cell blood group antigens: structure and function. Semin. Hematol.41 (2), 93–117 (2004).
   Web of Science ®Google Scholar
• Reid ME Lomas-Francis C Olsson ML . The Blood Group Antigen Factsbook. Elsevier/Academic Press, Amsterdam (2012).
   Google Scholar
• Anstee DJ . The relationship between blood groups and disease. Blood115 (23), 4635–4643 (2010).
   PubMed Web of Science ®Google Scholar
• Levine P Stetson RE . AN unusual case of intra-group agglutination. J. Am. Med. Assoc.113 (2), 126–127 (1939).
   Google Scholar
• Landsteiner K Wiener AS . An agglutinable factor in human blood recognized by immune sera for rhesus blood. Exp. Biol. Med.43 (1), 223–223 (1940).
   Google Scholar
• Avent ND Reid ME . The Rh blood group system: a review. Blood95 (2), 375–387 (2000).
   PubMed Web of Science ®Google Scholar
• Chou ST Westhoff CM . The Rh and RhAG blood group systems. Immunohematol. Am. Red Cross26 (4), 178–186 (2010).
   Google Scholar
• Huang CH Chen Y Reid ME Seidl C . Rhnull disease: the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood92 (2), 664–671 (1998).
   Web of Science ®Google Scholar
• Mouro-Chanteloup I D'Ambrosio AM Gane P et al. Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood100 (3), 1038–1047 (2002).
   PubMed Web of Science ®Google Scholar
• Chérif-Zahar B Bloy C Le Van Kim C et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc. Natl Acad. Sci. USA87 (16), 6243–6247 (1990).
   Web of Science ®Google Scholar
• Huang C-H Liu PZ . New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells. Mol. Dis.27 (1), 90–101 (2001).
   Web of Science ®Google Scholar
• Chou ST Jackson T Vege S Smith-Whitley K Friedman DF Westhoff CM . High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood122 (6), 1062–1071 (2013).
   PubMed Web of Science ®Google Scholar
• Rouger P Edelman L . Murine monoclonal antibodies associated with Rh17, Rh29, and Rh46 antigens. Transfusion28 (1), 52–55 (1988).
   Web of Science ®Google Scholar
• Nash R Shojania AM . Hematological aspect of Rh deficiency syndrome: a case report and a review of the literature. Am. J. Hematol.24 (3), 267–275 (1987).
   Web of Science ®Google Scholar
• Tilley L Green C Poole J et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang.98 (2), 151–159 (2010).
   Web of Science ®Google Scholar
• Gruswitz F Chaudhary S Ho JD et al. Function of human Rh based on structure of RhCG at 2.1 A. Proc. Natl Acad. Sci. USA107 (21), 9638–9643 (2010).
   Web of Science ®Google Scholar
• Hemker MB Cheroutre G van Zwieten R et al. The Rh complex exports ammonium from human red blood cells. Br. J. Haematol.122 (2), 333–340 (2003).
   Web of Science ®Google Scholar
• Westhoff CM . Deciphering the function of the Rh family of proteins. Transfusion45 (2 Suppl.), S117–S121 (2005).
   Web of Science ®Google Scholar
• Parsons SF Gardner B Anstee DJ . Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry and quantification of antigen sites. Transfus. Med. Oxf. Engl.3 (2), 137–142 (1993).
   Web of Science ®Google Scholar
• Jung HH Danek A Frey BM . McLeod syndrome: a neurohaematological disorder: McLeod syndrome. Vox Sang.93 (2), 112–121 (2007).
   Web of Science ®Google Scholar
• Tanner MJ . The structure and function of band 3 (AE1): recent developments (review). Mol. Membr. Biol.14 (4), 155–165 (1997).
   Web of Science ®Google Scholar
• Peters LL Shivdasani RA Liu SC et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell86 (6), 917–927 (1996).
   Web of Science ®Google Scholar
• Bruce LJ Tanner MJ . Erythroid band 3 variants and disease. Baillières Best Pract. Res. Clin. Haematol.12 (4), 637–654 (1999).
   Web of Science ®Google Scholar
• Figueroa D . The Diego blood group system: a review. Immunohematol. Am. Red Cross29 (2), 73–81 (2013).
   Google Scholar
• Reid ME . MNS blood group system: a review. Immunohematol. Am. Red Cross25 (3), 95–101 (2009).
   Google Scholar
• Chasis JA Mohandas N Shohet SB . Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. Evidence for a ligand-induced association between glycophorin A and skeletal proteins. J. Clin. Invest.75 (6), 1919–1926 (1985).
   Web of Science ®Google Scholar
• Knowles DW Chasis JA Evans EA Mohandas N . Cooperative action between band 3 and glycophorin A in human erythrocytes: immobilization of band 3 induced by antibodies to glycophorin A. Biophys. J.66 (5), 1726–1732 (1994).
   Web of Science ®Google Scholar
• Greineder CF Howard MD Carnemolla R Cines DB Muzykantov VR . Advanced drug delivery systems for antithrombotic agents. Blood122 (9), 1565–1575 (2013).
   PubMed Web of Science ®Google Scholar
• Rungaldier S Oberwagner W Salzer U Csaszar E Prohaska R . Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains. Biochim. Biophys. Acta1828 (3), 956–966 (2013).
   PubMed Web of Science ®Google Scholar
• Lomas-Francis C Reid ME . The Dombrock blood group system: a review. Immunohematol. Am. Red Cross26 (2), 71–78 (2010).
   Google Scholar
• Ballif BA Helias V Peyrard T et al. Disruption of SMIM1 causes the Vel−blood type. EMBO Mol. Med.5 (5), 751–761 (2013).
   Web of Science ®Google Scholar
• Storry JR Jöud M Christophersen MK et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat. Genet.45 (5), 537–541 (2013).
   Web of Science ®Google Scholar
• Helias V Saison C Ballif BA et al. ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis. Nat. Genet.44 (2), 170–173 (2012).
   Web of Science ®Google Scholar
• Sirchia G Zanella A Parravicini A Morelati F Rebulla P Masera G . Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion25 (2), 110–112 (1985).
   PubMed Web of Science ®Google Scholar
• Vichinsky EP Earles A Johnson RA Hoag MS Williams A Lubin B . Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N. Engl. J. Med.322 (23), 1617–1621 (1990).
   PubMed Web of Science ®Google Scholar
• Aminoff D Bruegge WF Bell WC Sarpolis K Williams R . Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase-treated and untreated erythrocytes with spleen and liver at the cellular level. Proc. Natl Acad. Sci. USA74 (4), 1521–1524 (1977).
   Web of Science ®Google Scholar
• Lenny LL Hurst R Goldstein J Benjamin LJ Jones RL . Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers. Blood77 (6), 1383–1388 (1991).
   PubMed Web of Science ®Google Scholar
• Lenny LL Hurst R Goldstein J Galbraith RA . Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O. Transfusion34 (3), 209–214 (1994).
   Web of Science ®Google Scholar
• Lenny LL Hurst R Zhu A Goldstein J Galbraith RA . Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials. Transfusion35 (11), 899–902 (1995).
   Web of Science ®Google Scholar
• Kruskall MS AuBuchon JP Anthony KY et al. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion40 (11), 1290–1298 (2000).
   PubMed Web of Science ®Google Scholar
• Falk P Hoskins LC Lindstedt R Svanborg C Larson G . Deantigenation of human erythrocytes by bacterial glycosidases–evidence for the noninvolvement of medium-sized glycosphingolipids in the Dolichos biflorus lectin hemagglutination. Arch. Biochem. Biophys.290 (2), 312–319 (1991).
   Web of Science ®Google Scholar
• Goldstein J . Preparation of transfusable red cells by enzymatic conversion. Prog. Clin. Biol. Res.165, 139–157 (1984).
   Google Scholar
• Goldstein J . Conversion of ABO blood groups. Transfus. Med. Rev.3 (3), 206–212 (1989).
   PubMedGoogle Scholar
• Hata J Dhar M Mitra M et al. Purification and characterization of N-acetyl-alpha-D-galactosaminidase from Gallus domesticus. Biochem. Int.28 (1), 77–86 (1992).
   Google Scholar
• Hoskins LC Boulding ET . Changes in immunologic properties of group A RBCs during treatment with an A-degrading exo-α-N-acetylgalactosaminidase. Transfusion41 (7), 908–916 (2001).
   Web of Science ®Google Scholar
• Hoskins LC Boulding ET Larson G . Purification and characterization of blood group A-degrading isoforms of alpha-N-acetylgalactosaminidase from Ruminococcus torques strain IX-70. J. Biol. Chem.272 (12), 7932–7939 (1997).
   Web of Science ®Google Scholar
• Hsieh H-Y Smith D . Clostridium perfringens alpha-N-acetylgalactosaminidase blood group A2-degrading activity. Biotechnol. Appl. Biochem.37 (2), 157–163 (2003).
   Google Scholar
• Izumi K Yamamoto K Tochikura T Hirabayashi Y . Blood substitutes, present and future perspectives [Internet] α-N-acetylgalactosaminidase from Acremonium sp. Biochim. Biophys. Acta1116 (1), 72–74 (1992).
   Google Scholar
• Zhu A Monahan C Wang ZK Goldstein J . Expression, purification, and characterization of recombinant alpha-N-acetylgalactosaminidase produced in the yeast Pichia pastoris. Protein Expr. Purif.8 (4), 456–462 (1996).
   Web of Science ®Google Scholar
• Liu QP Sulzenbacher G Yuan H et al. Bacterial glycosidases for the production of universal red blood cells. Nat. Biotechnol.25 (4), 454–464 (2007).
   Web of Science ®Google Scholar
• Olsson ML Clausen H . Modifying the red cell surface: towards an ABO-universal blood supply. Br. J. Haematol.140 (1), 3–12 (2008).
   Web of Science ®Google Scholar
• Tsuchida E . Blood Substitutes, Present and Future Perspectives [Internet]. Elsevier Science. http://books.google.com/books?id=IvnREjqUiKIC.
   Google Scholar
• Armstrong JK Meiselman HJ Fisher TC . Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity. Am. J. Hematol.56 (1), 26–28 (1997).
   Web of Science ®Google Scholar
• Murad KL Mahany KL Brugnara C Kuypers FA Eaton JW Scott MD . Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood93 (6), 2121–2127 (1999).
   Web of Science ®Google Scholar
• Scott MD Murad KL Koumpouras F Talbot M Eaton JW . Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc. Natl Acad. Sci. USA94 (14), 7566–7571 (1997).
   PubMed Web of Science ®Google Scholar
• Wang D Kyluik DL Murad KL Toyofuku WM Scott MD . Polymer-mediated immunocamouflage of red blood cells: effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells. Sci. China Life Sci.54 (7), 589–598 (2011).
   Web of Science ®Google Scholar
• Bradley AJ Murad KL Regan KL Scott MD . Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim. Biophys. Acta1561 (2), 147–158 (2002).
   Web of Science ®Google Scholar
• Neu B Armstrong JK Fisher TC Bäumler H Meiselman HJ . Electrophoretic mobility of human red blood cells coated with poly(ethylene glycol). Biorheology38 (5–6), 389–403 (2001).
   Web of Science ®Google Scholar
• Rossi NAA Constantinescu I Kainthan RK Brooks DE Scott MD Kizhakkedathu JN . Red blood cell membrane grafting of multi-functional hyperbranched polyglycerols. Biomaterials31 (14), 4167–4178 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Z Janzen J Brooks DE . Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells. Biomaterials31 (12), 3364–3373 (2010).
   Web of Science ®Google Scholar
• Janvier F Zhu JXX Armstrong J Meiselman HJ Cloutier G . Effects of amphiphilic star-shaped poly(ethylene glycol) polymers with a cholic acid core on human red blood cell aggregation. J. Mech. Behav. Biomed. Mater.18, 100–107 (2013).
   Web of Science ®Google Scholar
• Moghimi SM Hunter AC Dadswell CM Savay S Alving CR Szebeni J . Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. Biochim. Biophys. Acta1689 (2), 103–113 (2004).
   PubMed Web of Science ®Google Scholar
• Szebeni J . Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology216 (2–3), 106–121 (2005).
   PubMed Web of Science ®Google Scholar
• Kyluik-Price DL Li L Scott MD . Comparative efficacy of blood cell immunocamouflage by membrane grafting of methoxypoly(ethylene glycol) and polyethyloxazoline. Biomaterials35 (1), 412–422 (2014).
   Web of Science ®Google Scholar
• Armstrong JK Hempel G Koling S et al. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer110 (1), 103–111 (2007).
   PubMed Web of Science ®Google Scholar
• Chambers E Mitragotri S . Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J. Control. Release100 (1), 111–119 (2004).
   PubMed Web of Science ®Google Scholar
• Anselmo AC Gupta V Zern BJ et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano7 (12), 11129–11137 (2013).
   PubMed Web of Science ®Google Scholar
• Chen K Merkel TJ Pandya A et al. Low modulus biomimetic microgel particles with high loading of hemoglobin. Biomacromolecules13 (9), 2748–2759 (2012).
   PubMed Web of Science ®Google Scholar
• Doshi N Zahr AS Bhaskar S Lahann J Mitragotri S . Red blood cell-mimicking synthetic biomaterial particles. Proc. Natl Acad. Sci. USA106 (51), 21495–21499 (2009).
   PubMed Web of Science ®Google Scholar
• Merkel TJ Jones SW Herlihy KP et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl. Acad. Sci.108 (2), 586–591 (2011).
   PubMed Web of Science ®Google Scholar
• Rodriguez PL Harada T Christian DA Pantano DA Tsai RK Discher DE . Minimal “self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science339 (6122), 971–975 (2013).
   PubMed Web of Science ®Google Scholar
• Koshida S Asanuma K Kuribayashi K et al. Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations. Clin. Chim. Acta411 (5–6), 391–394 (2010).
   Web of Science ®Google Scholar
• Kricka LJ . Human anti-animal antibody interferences in immunological assays. Clin. Chem.45 (7), 942–956 (1999).
   PubMed Web of Science ®Google Scholar
• Winter G Milstein C . Man-made antibodies. Nature349 (6307), 293–299 (1991).
   PubMed Web of Science ®Google Scholar
• Bratkovic T . Progress in phage display: evolution of the technique and its application. Cell. Mol. Life Sci. CMLS67 (5), 749–767 (2010).
   PubMed Web of Science ®Google Scholar
• Geyer CR McCafferty J Dübel S Bradbury ARM Sidhu SS . Recombinant antibodies and in vitro selection technologies. Methods Mol. Biol.901, 11–32 (2012).
   PubMedGoogle Scholar
• Siegel DL . Phage display-based molecular methods in immunohematology. Transfusion47 (1 Suppl.), S89–S94 (2007).
   Web of Science ®Google Scholar
• Aitken R . Antibody Phage Display: Methods and Protocols. Humana, NY, USA (2009).
   Google Scholar
• Barbas CF . Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press. http://books.google.com/books?id=V7bwAAAAMAAJ.
   Google Scholar
• Clackson T Lowman HB . Phage Display: A Practical Approach. Oxford University Press. http://books.google.com/books?id=CQ1rnQEACAAJ.
   Google Scholar
• Sidhu SS Geyer CR . Phage Display In Biotechnology and Drug Discovery. Taylor & Francis. http://books.google.com/books?id=_xvXhluNfrkC.
   Google Scholar
• Smith GP . Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science228 (4705), 1315–1317 (1985).
   PubMed Web of Science ®Google Scholar
• Burton DR Barbas CF Persson MA Koenig S Chanock RM Lerner RA . A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl Acad. Sci. USA88 (22), 10134–10137 (1991).
   PubMed Web of Science ®Google Scholar
• Persson MA Caothien RH Burton DR . Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl Acad. Sci. USA88 (6), 2432–2436 (1991).
   Web of Science ®Google Scholar
• Chang TY Siegel DL . Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood91 (8), 3066–3078 (1998).
   Web of Science ®Google Scholar
• Chang TY Siegel DL . Isolation of an IgG anti-B from a human Fab-phage display library. Transfusion41 (1), 6–12 (2001).
   Web of Science ®Google Scholar
• Siegel DL Chang TY Russell SL Bunya VY . Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology. J. Immunol. Methods206 (1–2), 73–85 (1997).
   Web of Science ®Google Scholar
• Siegel DL Silberstein LE . Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating human red blood cell antibodies by repertoire cloning. Blood83 (8), 2334–2344 (1994).
   Web of Science ®Google Scholar
• Klein HG Anstee DJ . Mollison's Blood Transfusion in Clinical Medicine. Wiley, NY, USA (2013).
   Google Scholar
• Lloyd C Lowe D Edwards B et al. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng. Des. Sel. PEDS22 (3), 159–168 (2009).
   Web of Science ®Google Scholar
• Schofield DJ Pope AR Clementel V et al. Application of phage display to high throughput antibody generation and characterization. Genome Biol.8 (11), R254 (2007).
   PubMed Web of Science ®Google Scholar
• Martineau P . Error-prone polymerase chain reaction for modification of scFvs. In : Methods Mol. Biol.Clifton NJ. 178, 287–294 (2002).
   Google Scholar
• Thie H Voedisch B Dübel S Hust M Schirrmann T . Affinity maturation by phage display. In : Therapeutic Antibodies. DimitrovAS ( Ed.). Humana Press, NY, USA, 309–322 (2009).
   Google Scholar
• Nishibori N Horiuchi H Furusawa S Matsuda H . Humanization of chicken monoclonal antibody using phage-display system. Mol. Immunol.43 (6), 634–642 (2006).
   Web of Science ®Google Scholar
• Popkov M Mage RG Alexander CB Thundivalappil S Barbas CF Rader C . Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. J. Mol. Biol.325 (2), 325–335 (2003).
   Web of Science ®Google Scholar
• Knappik A Ge L Honegger A et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol.296 (1), 57–86 (2000).
   PubMed Web of Science ®Google Scholar
• Krebs B Rauchenberger R Reiffert S et al. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods254 (1–2), 67–84 (2001).
   PubMed Web of Science ®Google Scholar
• Jespers LS Roberts A Mahler SM Winter G Hoogenboom HR . Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnol. Nat. Publ. Co.12 (9), 899–903 (1994).
   Google Scholar
• Osbourn J Groves M Vaughan T . From rodent reagents to human therapeutics using antibody guided selection. Methods San Diego Calif.36 (1), 61–68 (2005).
   Web of Science ®Google Scholar
• Shi J Kundrat L Pishesha N et al. Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes. Proc. Natl Acad. Sci. USA111 (28), 10131–10136 (2014).
   PubMed Web of Science ®Google Scholar